Material Type

• Blood (whole) (3)
• Dried whole blood (3)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Other (2)
• Pathogen DNA (Derivative) (1)
• Plasma (single spun) (6)
• Saliva (2)
• Serum (4)
• Sputum (1)
• Stool (2)
• Swab medium (4)
• Urine (random) (2)

Microscopic Assessment

• Affected (2)
• Not applicable (9)

Storage Temperature

• RT (2)
• -35°C to -18°C (1)
• -85°C to -60°C (10)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (7)
• Followup records (5)
• Freezer temperature logs (5)
• Genomic datasets (2)
• Microbiological results (5)
• Participant Ethnicity (3)
• Physiological/biochemical measurements (4)
• Pre-analytical data (3)
• Quality indicators (3)
• Survey data (5)
• Treatment records (4)

Timeframe

• Immediate (3)
• 0 - 3 months (6)
• 3 - 6 months (4)
• > 6 months (2)

Participant Count

• 11 - 100 (1)
• 101 - 500 (8)
• 501 - 1000 (1)
• 10001 - 50000 (1)

Sex

• Both sexes (10)

Age Range

• Young adult (18 - 40 years) (10)

Biobank Services

• Ability to recontact (3)
• Cell culture (2)
• Data analytics (3)
• Infectious strain isolation (2)
• Molecular Extractions (2)
• Nucleic acid extraction (2)

Collection Type

• (1)
• Case-control (1)
• Clinical Trial (2)
• Cross-sectional (2)
• Disease specific (4)
• Population-based (1)

Consent Restriction

• No Commercial restriction (7)
• No Disease area restriction (8)
• No Genetic analysis restriction (10)
• No Human genetic analysis restriction (8)
• No restrictions (2)
• No Project specific restriction (8)
• No Scope of use restriction (6)

Collection Status

• Completed (3)
• In progress (6)
• Not-started (1)

Access Condition

• Open to applicants (4)
• Open only through collaboration (6)

Country

• Belgium (1)
• Democratic Republic of the Congo (2)
• India (1)
• Kenya (1)
• Peru (1)
• South Africa (1)
• Switzerland (1)
• Uganda (1)
• United States (1)

County